1.6.20 | Policy
A Call to Improve Suicide Prevention for Women Veterans
Women veterans are two times more likely than non-veteran women to die by suicide, and there is a dire need to improve their access to mental health services.
12.23.19 | Policy
SWHR Feedback to FDA on Health of Women Strategic Plan
In comments to the U.S. Food and Drug Administration’s Center for Devices and Radiological Health (CDRH), SWHR provided feedback on […]
12.11.19 | Policy
SWHR Policy Advisory Council Meeting
The Policy Advisory Council is a forum for industry, nonprofit, and other health care stakeholders to partner with SWHR to support emerging scientific research and public policy that will improve women’s health.
12.11.19 | Policy
SWHR Policy Advisory Council Meeting
The Policy Advisory Council is a forum for industry, nonprofit, and other health care stakeholders to partner with SWHR to support emerging scientific research and public policy that will improve women’s health.
12.11.19 | Policy
SWHR Policy Advisory Council Meeting
The Policy Advisory Council is a forum for industry, nonprofit, and other health care stakeholders to partner with SWHR to support emerging scientific research and public policy that will improve women’s health.
12.11.19 | Policy
SWHR Policy Advisory Council Meeting
The Policy Advisory Council is a forum for industry, nonprofit, and other health care stakeholders to partner with SWHR to support emerging scientific research and public policy that will improve women’s health.
12.3.19 | Policy
Building Consumer Confidence by Empowering FDA to Improve Cosmetic Safety
The House Energy and Commerce Health Subcommittee holds a hearing on "Building Consumer Confidence by Empowering FDA to Improve Cosmetic Safety."
11.4.19 | Policy
SWHR Develops Principles to Ensure Health Care Value Assessments Work for Women
When a new health care innovation comes to market, how do patients, health care providers, and health care payers determine its value?
10.22.19 | Policy
SWHR Urges Women’s Health Focus in U.S. Biotechnology Investment
In a letter to the White House Office of Science and Technology Policy (OSTP), SWHR recommended the government prioritize biotechnology […]
10.18.19 | Policy
SWHR Recommendations on ICER’s 2020 Value Assessment Framework
SWHR provided recommendations to the Institute for Clinical and Economic Review (ICER) on proposed changes to its 2020 value assessment […]
